How would a Biden White House handle drug prices? Depends on congressional races, analysts say

This fall’s national elections, presidential and otherwise, could affect the pharma industry’s fate in the coming years. Democratic presumptive nominee Joe Biden has some aggressive proposals on drug pricing, and while analysts see some as possible, others are more unlikely, they say.